These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 918599)

  • 1. [Distinction between benign and malignant monoclonal gammopathies on the basis of bone marrow and serum studies].
    Morell A; Skvaril F; Spengler G; Barandun S
    Schweiz Med Wochenschr; 1977 Oct; 107(41):1463. PubMed ID: 918599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation between benign and malignant monoclonal gammopathies by discriminant analysis on serum and bone marrow parameters.
    Morell A; Maurer W; Skvaril F; Barandun S
    Acta Haematol; 1978; 60(3):129-36. PubMed ID: 101000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation between benign and malignant monoclonal gammopathy by the presence of the J chain.
    Bast EJ; Van Camp B; Boom SE; Jaspers FC; Ballieux RE
    Clin Exp Immunol; 1981 May; 44(2):375-82. PubMed ID: 6796314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytological study of acid phosphatase activity of plasma cells in monoclonal gammopathies].
    Ricci C; Coscia GG; Bellone G; Novarini M; Discalzi GL; Cascio G
    Acta Med Austriaca; 1984; 11(2):37-43. PubMed ID: 6741437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contribution of bone biopsy with histomorphometry in the evaluation of monoclonal gammopathy].
    Alexandre C; Bataille R; Chappard D; Dessauw P; Sany J; Riffat G
    Rev Rhum Mal Osteoartic; 1987 Nov; 54(11):717-21. PubMed ID: 3423714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal gammopathy of undetermined significance (MGUS): a review.
    Kyle RA
    Clin Haematol; 1982 Feb; 11(1):123-50. PubMed ID: 6804144
    [No Abstract]   [Full Text] [Related]  

  • 8. B lymphocyte markers in multiple myeloma and related plasma cell dyscrasias.
    Ricci C; Coscia G; Bozzone DM; Canavera RM; Baldassi R; Cascio G; Anania A; Marchi L; Verney MM
    Cancer Detect Prev; 1988; 11(3-6):423-32. PubMed ID: 3260538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Milanesi B; Tafuri C; Perini M; Rota G; Peretti P
    Quad Sclavo Diagn; 1984 Jun; 20(2):149-54. PubMed ID: 6528014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow percentage of plasma cells in the staging of monoclonal gammopathies.
    Vercelli D; Di Guglielmo R; Guidi G; Scolari L; Buricchi L; Cozzolino F
    Nouv Rev Fr Hematol (1978); 1980; 22(2):139-45. PubMed ID: 7422542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interpretation of minimal medullary plasmacytoses in monoclonal dysglobulinemias. Importance of the study of osteomedullary biopsies of semi-thin sections and immunologic marking].
    Canioni D; Kermarec J
    Ann Pathol; 1982; 2(4):279-92. PubMed ID: 6760876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum beta 2-microglobulin, serum creatinine and bone marrow plasma cells in benign and malignant monoclonal gammopathy.
    Morell A; Riesen W
    Acta Haematol; 1980; 64(2):87-93. PubMed ID: 6159767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
    Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G
    J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal gammopathy of undetermined significance: a morphologic and immunophenotypic study of the bone marrow.
    Feiner HD; Bannan M; Marsh E; Chuba JV; Espiritu E; Gottesman SR
    Mod Pathol; 1992 Jul; 5(4):372-9. PubMed ID: 1495943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Santus G; Pirali F; Inzoli MR
    Minerva Med; 1981 Sep; 72(37):2479-83. PubMed ID: 7279268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytochemistry in the differential diagnosis of patients with a monoclonal component].
    Portero JA; Martín S
    Sangre (Barc); 1984; 29(5):907-12. PubMed ID: 6441293
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytochemical studies of bone marrow plasma cells in monoclonal gammapathies (author's transl)].
    Miliani A; Anichini P; di Guglielmo R; Pellegrini G; Firorelli C; Cuccuini A; Cozzolino F; Vercelli D
    Nouv Rev Fr Hematol (1978); 1982; 24(1):27-33. PubMed ID: 6461844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic immunoglobulins in bone marrow cells of polyclonal and of monoclonal origin.
    Morell A; Skvaril F; Huser HJ; Spengler G; Barandun S
    Acta Haematol; 1978; 60(3):137-47. PubMed ID: 101001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal gammopathies and aging.
    Cohen HJ
    Hosp Pract (Off Ed); 1988 Mar; 23(3A):75-80, 82, 85-9 passim. PubMed ID: 3127410
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders.
    Menke DM; Greipp PR; Colon-Otero G; Solberg LA; Cockerill KJ; Hook CC; Witzig TE
    Arch Pathol Lab Med; 1994 Aug; 118(8):811-4. PubMed ID: 7520228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.